Ladostigil hemitartrate (Standard)

Overview

Ladostigil hemitartrate (Standard) is the analytical standard of Ladostigil hemitartrate ( HY-10400 ). This product is intended for research and analytical applications. Ladostigil (TV-3326) hemitartrate is an orally active dual inhibitor of cholinesterase and brain-selective monoamine oxidase (MAO), with IC 50 s of 37.1 and 31.8 μM for MAO-B and AChE , respectively. Ladostigil hemitartrate exhibits neuroprotective, antioxidant and anti-inflammatory activities. Ladostigil hemitartrate can be used for the research of depression and Alzheimer's disease. Ladostigil hemitartrate is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Monoamine Oxidase | Products > Signaling Pathways > Cholinesterase (ChE)

Product Information

• Catalog No.: HY-10400R
• CAS No.: 209394-46-7
• Molecular Formula: C16H20N2O2·1/2C4H6O6
• Molecular Weight: 347.40
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source